Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group.
about
Debate: Unstable angina - When should we intervene?Implications of troponin testing in clinical medicineArterial indications for the low molecular weight heparinsCost effectiveness of extended treatment with low molecular weight heparin (dalteparin) in unstable coronary artery disease: results from the FRISC II trialContemporary management of acute coronary syndromePolyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells.Cardiac troponin I and troponin T: recent players in the field of myocardial markers.Endothelial cell fibrinolysis: transcriptional regulation of fibrinolytic protein gene expression (t-PA, u-PA, and PAI-1) by low alcohol.New antithrombotic and antiplatelet treatment.Regular review: treatment possibilities for unstable angina.Risk stratification and therapeutic decision making in patients with acute coronary syndrome--the role of cardiac troponin T.Troponin and other cardiac markers: role in management of acute coronary syndromes.Troponin: the biomarker of choice for the detection of cardiac injuryTherapy of unstable angina with the low molecular weight heparins.Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein.Dalteparin sodium.Risk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines.Risk factors for coronary disease: the time for a paradigm shift?Cardiac markers in the early diagnosis and management of patients with acute coronary syndromeMulticentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practiceLong term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring.The role of low-molecular-weight heparins in cardiovascular medicine.Biochemical advances in detection of the acute coronary syndromes: Implications for therapeutic decisions.Biomarkers of cardiac injury: an update.Present and future biochemical markers for detection of acute coronary syndrome.Multimarker strategy in acute coronary syndrome--pro-multimarker.Biomarkers of cardiovascular damage.Biomarkers in Acute Coronary Syndrome.Cardiac troponins I and T: molecular markers for early diagnosis, prognosis, and accurate triaging of patients with acute myocardial infarction."Troponin elevation in coronary ischemia and necrosis".Making sense of high sensitivity troponin assays and their role in clinical care.Diagnostic accuracy of sensitive or high-sensitive troponin on presentation for myocardial infarction: a meta-analysis and systematic review.Diagnosis and management of patients with suspected acute myocardial infarction.Use of a quantitative point-of-care test for the detection of serum cardiac troponin T in patients with suspected acute coronary syndromes.Comparison of cardiac troponin I and creatine kinase ratios in the detection of myocardial injury after aortic surgery.Combined Assessments of Biochemical Markers and ST-Segment Resolution Provide Additional Prognostic Information for Patients With ST-Segment Elevation Myocardial Infarction.Cardiac troponins in chest pain can help in risk stratification.Randomised controlled trial of chest pain units is neededCALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis.Can electrocardiographic criteria predict adverse cardiac events and positive cardiac markers?
P2860
Q24792327-8F89B30D-89D8-4EC8-8213-7BCF488AD735Q24793067-FCF4489C-82C9-401A-AEE9-0395D1E6D554Q24806932-60A31E47-15E8-4431-9181-1718C0EB1AAEQ28194967-058528CF-F84C-49EB-8662-21F55C30AB4DQ28212068-37048278-0186-4611-9960-64D6FD9F9DD7Q32117355-4D5288F8-9D97-485C-964B-416BBAB5FE44Q33545643-CE38848C-33BE-49C8-8C2E-F03965E088D0Q33682413-996B650A-C142-4308-8714-0BE558DC0B98Q33723971-000FCCF7-4226-44E9-A199-6B5EBB12F0EFQ33802938-0AC3ECF2-0368-47FB-8948-904CBF32104DQ33869017-FAA6A138-4BF5-4D6A-AF83-6F8E96ACD8CDQ33951280-59B1EBE0-FEB8-41D3-8A89-966752729024Q34117708-2D0F4962-8C3A-4F45-8530-9EA4E2AD7D95Q34158934-BD8184D2-78B0-4B90-9225-F8139579474DQ34306830-DE6AE7C8-3B4C-4D06-B305-08CE1BFD0C86Q34390254-7821F167-89EA-4081-A659-027B749213F2Q34445660-3062F5DF-28B6-4ACB-9716-9B74F5B52467Q34471608-032F32F7-7A17-4F8D-AD9E-D9E9CE387D56Q34782895-586AFE02-11B1-4137-AD77-9D25941C13F2Q35580971-35FD6F2E-8F43-4F88-A3C4-733A92911BFBQ35582508-6A662D34-930B-4DB5-982B-BC8A162D3FB2Q35591215-4F483CF4-B3E3-4133-AF32-4021A23DD92DQ36264135-7F4FC987-0C67-48F9-9C70-623C1102CAC0Q36331264-2B6E2139-AF00-4C0B-8259-0CED0FB1B3CBQ36624223-F4310C47-E664-48CA-876C-27D8B1203997Q36799327-786F6C8C-F1BA-48A0-A721-08A619030684Q36836546-27D676D1-170D-48D5-B7BB-F2AF91D0582BQ37207294-F9D73FDA-2DD1-45D2-A824-5B62E3C61605Q38062864-85BB2189-64A4-4F44-A4B6-AD7F63821A94Q38178539-82C19525-ADC1-4319-8BFB-051497610D83Q38192517-8551E782-C3BD-48EE-80DD-7442AC1CA6E2Q38237059-DF7E32FB-9F6E-4075-B7F6-9BB37B7324D3Q40395526-A9A426D2-FA7F-404A-BC4A-71AE2B6CDB54Q40396541-C737F0C2-6753-40C4-AC1C-5AB81F57CA13Q42044388-C3568977-A33B-42BD-B3A6-7BCA50078B30Q42122291-87C49C1A-6C85-4765-97FA-988F05BDBFACQ42765345-31D684DF-5528-4D8E-A320-C5FD1E55C11BQ42768618-4E34C9D7-3805-40A6-AC4E-E13F2BD83AACQ42951347-2F0A34E0-61B5-4D17-9C7C-830B3189040EQ44342028-C1A4FA1E-004B-490C-A90A-CB75ED207BFD
P2860
Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Troponin T identifies patients ...... y Disease (FRISC) Study Group.
@en
Troponin T identifies patients ...... stable Coronary Artery Disease
@nl
type
label
Troponin T identifies patients ...... y Disease (FRISC) Study Group.
@en
Troponin T identifies patients ...... stable Coronary Artery Disease
@nl
prefLabel
Troponin T identifies patients ...... y Disease (FRISC) Study Group.
@en
Troponin T identifies patients ...... stable Coronary Artery Disease
@nl
P2093
P1476
Troponin T identifies patients ...... y Disease (FRISC) Study Group.
@en
P2093
P356
10.1016/S0735-1097(96)00447-0
P407
P577
1997-01-01T00:00:00Z